Overview
It Takes a Village: Working Together to Reduce Racial Inequities in Maternal Morbidity and Mortality
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
Maternal morbidity and mortality rates are unacceptably high in the United States (US). In fact, Black women are two to three times more likely to die from pregnancy-related causes than white women, prompting the US Department of Health and Human Services to state that maternal deaths are a public health crisis. What can you do to address these inequities in maternal health? Two experts in this field will discuss the latest data on maternal deaths and frame practical and supportive strategies that providers can implement.
This activity is intended for primary care physicians, public health professionals, physician assistants, nurse practitioners, nurses, and any other clinicians who treat or commonly encounter pregnant women.
Maternal morbidity and mortality in the United States outpaces that of other developed, high-income countries. Further, racial and ethnic disparities persist with rates of maternal deaths more than two- to threefold higher in Black women. A complex interplay between individual, clinical, behavioral, and social determinants negatively impact maternal outcomes. As such, multifaceted, sustained interventions are needed to address these disparities. Examples include integration of social needs into healthcare, increased attention to maternal care before and after birth, delivery of respectful and culturally appropriate care, and implementation of policy changes that address the core tenants of disparate care.
Upon completion of this activity, learners will be able to:
- Identify racial and ethnic disparities as evidenced by data on maternal deaths
- Outline factors that disproportionately impact maternal morbidity and mortality in racial and ethnic patients
- Describe strategies to address inequities in maternal healthcare
Provided by the Academy for Continued Healthcare Learning (ACHL).
This education is brought to you by the Academy for Continued Healthcare Learning (ACHL).
.jpg)
Stacie Geller, PhD
Professor of Obstetrics and Gynecology
Professor, Division of Academic Internal Medicine
Department of Medicine and Director
Center for Research on Women and Gender
College of Medicine at University of Illinois in Chicago
.jpg)
Dara Mendez, PhD, MPH
Associate Professor of Epidemiology
University of Pittsburgh School of Public Health
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships within 24 months (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with all ineligible companies. All relevant financial relationships have been mitigated prior to this activity.
The following financial relationships have been provided:
Stacie Gellar, PhD, (Faculty)
No financial relationships to disclose.
Dara Mendez, PhD, MPH, (Faculty)
No financial relationships to disclose.
Discussion of Off-Label, Investigational, or Experimental Drug/Devise Use: None
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of any ineligible company. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor(s).
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 45 minutes to complete. To receive credit, learners are required to view the online activity, and complete the evaluation. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions, call Karen Catino (773) 714-0705, ext 128
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion as AAPA, AANP, and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.
